Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: pathology

New Market Channel For Esoteric Testing

Clinical Laboratory / By Robert Michel

CEO SUMMARY: It’s a new marketing model for specialty esoteric tests that presents both clinical and financial challenges to hospital and health system laboratories. Niche labs offering esoteric tests are sending sales reps directly to physicians and bypassing pathologists and lab directors at local hospital laboratories. These tests come bundled in high-priced panels and often …

New Market Channel For Esoteric Testing Read More »

To access this post, you must purchase The Dark Report.

“January 20, 2003 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By Robert Michel

December proved to be an eventful month for many companies in the lab industry. Here’s some key items of interest, many to be followed in more detail in coming issues of THE DARK REPORT: •AmeriPath, Inc. is to be sold to Welsh, Carson, Anderson & Stowe, a private equity firm in New York. Welsh Carson …

“January 20, 2003 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Grasping the Impact of the Genetic Revolution

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

IT’S BEEN SEVEN MONTHS since healthcare futurist Rick J. Carlson shared his insights about the impending genomic/proteomic revolution at the Executive War College in NewnOrleans last May. A key theme of his message was that diagnostic services would be squarely in the middle of the coming genetics tidal wave. Carlson, President of Health Strategies Group …

Grasping the Impact of the Genetic Revolution Read More »

To access this post, you must purchase The Dark Report.

Laboratories Sit Squarely Between New Genetics and Today’s Medicine

The Dark Report / By Robert Michel

“Clinical laboratories and pathology groups are at the leading edge of the genetic revolution.” —Rick J. Carlson. CEO SUMMARY: Healthcare futurist Rick J. Carlson believes that knowledge of the human genome will trigger revolutionary changes in the American healthcare system. In particular, Carlson predicts consumers will drive the primary shift in the way healthcare services …

Laboratories Sit Squarely Between New Genetics and Today’s Medicine Read More »

To access this post, you must purchase The Dark Report.

Several Major Surprises Mark Events of 2002

The Dark Report / By Robert Michel

CEO SUMMARY: It was a year when the two blood brothers got much bigger and expanded market share by buying their largest competitors. With patient safety as the goal, employers began active steps to force hospitals, physicians, and other healthcare providers to use quality management systems to reduce errors. Unpredictable in many ways, 2002 set …

Several Major Surprises Mark Events of 2002 Read More »

To access this post, you must purchase The Dark Report.

More Consolidation: Where Will It Lead?

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

I CERTAINLY DID NOT FORESEE ALL THE LAB ACQUISITION ACTIVITY that occurred during 2002. Compared to recent years, both Quest Diagnostics Incorporated and Laboratory Corporation of America have been on a buying spree this year. Quest Diagnostics acquired American Medical Laboratories in April and has an agreement to acquire Unilab Corporation, pending a decision by …

More Consolidation: Where Will It Lead? Read More »

To access this post, you must purchase The Dark Report.

Another Lab Acquisition: LabCorp To Buy DIANON

The Dark Report / By Robert Michel

CEO SUMMARY: Laboratory Corporation of America Holdings will pay almost $598 million to buy DIANON Systems, Inc. of Stratford, Connecticut. With this move, anatomic pathology becomes a high profile growth target for LabCorp. During the past eight years, DIANON Systems has built a national business providing highly specialized anatomic pathology and esoteric testing services to …

Another Lab Acquisition: LabCorp To Buy DIANON Read More »

To access this post, you must purchase The Dark Report.

Why DIANON Sale Alters Anatomic Path Market

The Dark Report / By Robert Michel

CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic pathologists have ample warning that new national competitors will soon attempt to capture local physician accounts. …

Why DIANON Sale Alters Anatomic Path Market Read More »

To access this post, you must purchase The Dark Report.

“Direct-to-Consumer” Ad Runs in New York Times

The Dark Report / By Robert Michel

CEO SUMMARY: Two pioneering advertising campaigns launched in September. Both Myriad Genetics and IMPATH targeted consumers with advertisements about diagnostic testing. In each case, the most vocal response to the advertising came from within the medical community. Within the pathology profession, IMPATH’s full-page advertisement in the New York Times Sunday Magazine was not well-received by …

“Direct-to-Consumer” Ad Runs in New York Times Read More »

To access this post, you must purchase The Dark Report.

Disease Management Relies On Lab Testing

The Dark Report / By Robert Michel

CEO SUMMARY: Predictions are that 30% of large corporations will offer disease management programs for their employees by the end of next year. Disease management seems to be the next form of managed care, where prevention and early detection are the primary goals. Laboratories should be alert for opportunities to add value to these programs. …

Disease Management Relies On Lab Testing Read More »

To access this post, you must purchase The Dark Report.

;